Cargando…
Increased serum adiponectin predicts improved coronary flow and clinical outcomes in patients with ST‐segment elevation myocardial infarction treated by primary percutaneous coronary intervention
BACKGROUND: Previous studies suggested that adiponectin (APN) could ameliorate ischemia/reperfusion injury and endothelial dysfunction in patients with acute myocardial infarction. However, the relationship between serum APN level and coronary flow after primary percutaneous coronary intervention (P...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595347/ https://www.ncbi.nlm.nih.gov/pubmed/30779470 http://dx.doi.org/10.1002/jcla.22864 |